APGE
Price
$63.37
Change
-$0.46 (-0.72%)
Updated
Nov 20, 04:59 PM (EDT)
Capitalization
4.33B
Intraday BUY SELL Signals
CRNX
Price
$41.95
Change
-$0.96 (-2.24%)
Updated
Nov 20, 04:59 PM (EDT)
Capitalization
3.98B
104 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

APGE vs CRNX

Header iconAPGE vs CRNX Comparison
Open Charts APGE vs CRNXBanner chart's image
Apogee Therapeutics
Price$63.37
Change-$0.46 (-0.72%)
Volume$9.17K
Capitalization4.33B
Crinetics Pharmaceuticals
Price$41.95
Change-$0.96 (-2.24%)
Volume$17.79K
Capitalization3.98B
APGE vs CRNX Comparison Chart in %
APGE
Daily Signal:
Gain/Loss:
CRNX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
APGE vs. CRNX commentary
Nov 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Hold and CRNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 21, 2025
Stock price -- (APGE: $63.37 vs. CRNX: $41.97)
Brand notoriety: APGE and CRNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 78% vs. CRNX: 55%
Market capitalization -- APGE: $4.33B vs. CRNX: $3.98B
APGE [@Biotechnology] is valued at $4.33B. CRNX’s [@Biotechnology] market capitalization is $3.98B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.15B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileCRNX’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • CRNX’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 4 TA indicator(s) are bullish while CRNX’s TA Score has 2 bullish TA indicator(s).

  • APGE’s TA Score: 4 bullish, 4 bearish.
  • CRNX’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, APGE is a better buy in the short-term than CRNX.

Price Growth

APGE (@Biotechnology) experienced а +0.64% price change this week, while CRNX (@Biotechnology) price change was +1.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.65%. For the same industry, the average monthly price growth was -7.08%, and the average quarterly price growth was +60.39%.

Reported Earning Dates

CRNX is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (-1.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($4.33B) has a higher market cap than CRNX($3.98B). APGE YTD gains are higher at: 39.890 vs. CRNX (-17.915). APGE has higher annual earnings (EBITDA): -270.1M vs. CRNX (-419.62M). CRNX has more cash in the bank: 1.2B vs. APGE (505M). APGE has less debt than CRNX: APGE (10.8M) vs CRNX (49.9M). CRNX has higher revenues than APGE: CRNX (1.39M) vs APGE (0).
APGECRNXAPGE / CRNX
Capitalization4.33B3.98B109%
EBITDA-270.1M-419.62M64%
Gain YTD39.890-17.915-223%
P/E RatioN/AN/A-
Revenue01.39M-
Total Cash505M1.2B42%
Total Debt10.8M49.9M22%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
51
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APGECRNX
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 4 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 4 days ago
74%
Declines
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signal:
Gain/Loss:
CRNX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BLUEX39.27N/A
N/A
AMG Veritas Global Real Return I
MFEHX195.98N/A
N/A
MFS Growth R3
TGWRX14.68N/A
N/A
Transamerica Large Growth R
FLMFX10.12N/A
N/A
Meeder Muirfield Retail
SGRNX50.39N/A
N/A
Allspring Growth Inst

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
-0.72%
SYRE - APGE
59%
Loosely correlated
-3.42%
IRON - APGE
51%
Loosely correlated
-0.44%
NUVL - APGE
51%
Loosely correlated
+0.90%
ELVN - APGE
51%
Loosely correlated
-3.80%
CRNX - APGE
51%
Loosely correlated
-2.17%
More

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-2.17%
XNCR - CRNX
60%
Loosely correlated
-1.20%
CLDX - CRNX
53%
Loosely correlated
+0.60%
NUVL - CRNX
53%
Loosely correlated
+0.90%
IDYA - CRNX
53%
Loosely correlated
+0.09%
NRIX - CRNX
52%
Loosely correlated
+6.98%
More